This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Abstract Worldwide, valvular heartdisease (VHD) is a common cause of hospitalization for acute heart failure. In acute heart failure caused by VHD, symptoms result from rapid haemodynamic changes and subsequent decline in cardiac function, and if left untreated, leads to acute decompensation and cardiogenic shock.
Analysis of 13,587 patients undergoing isolated tricuspid valve surgery from 2017 to 2023 revealed a 5.5% The STS used recent national data from the STS Adult Cardiac Surgery Database between 2012 and 2023 to analyze outcomes of SAVR after previous TAVR. overall predicted risk of mortality for isolated repair and a 5.7%
“Edwards has a long history of leading innovation and pioneering new therapies to address the unmet needs of patients with structural heartdisease,” said Daveen Chopra , Edwards’ corporate vice president, transcatheter mitral and tricuspid therapies. “We
Cardiometabolic conditions – specifically obesity, diabetes and heartdisease – disproportionately affect the 60 million people in the U.S. Cultural customs like diet and lifestyle can be compounded by language barriers to create challenges in reducing the rates of these diseases. with Hispanic heritage.
Attendees can join with their peers and participate in sessions on structural heartdisease, congenital heartdisease, guidelines and trials, AI/Machine learning, technical aspects of cardiac CT, coronary artery disease, vascular heartdisease, debates and games and early career topics. 5:00 p.m.,
February 1, 2024 — As cardiologists, heartdisease patients and the organizations that serve them across the country embark on American Heart Month, DAIC has compiled a snapshot of significant cardiovascular disease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market. In addition, 115.9
A 76-year-old woman with a history of double valve replacement (Aortic and mitral valves) for rheumatic heartdisease, presented with acute dyspnea after a switch from Warfarin to LMWH before a planned bone marrow biopsy. The innovative double balloon catheter Inflation across the the mechanical prosthetic valve is possible.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content